Copyright Reports & Markets. All rights reserved.

Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 HIV POC
      • 1.4.3 Clostridium difficile POC
      • 1.4.4 HBV POC
      • 1.4.5 Pneumonia or Streptococcus associated infections
      • 1.4.6 Respiratory syncytial virus (RSV) POC
      • 1.4.7 HPV POC
      • 1.4.8 Influenza/Flu POC
      • 1.4.9 Other Infectious Disease POC
    • 1.5 Market by Application
      • 1.5.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Home
      • 1.5.5 Assisted Living Healthcare Facilities
      • 1.5.6 Laboratories
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Point-of-Care Infectious Disease Diagnostics/Testing Market Size
    • 2.2 Point-of-Care Infectious Disease Diagnostics/Testing Growth Trends by Regions
      • 2.2.1 Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions (2014-2025)
      • 2.2.2 Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Manufacturers
      • 3.1.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players Head office and Area Served
    • 3.3 Key Players Point-of-Care Infectious Disease Diagnostics/Testing Product/Solution/Service
    • 3.4 Date of Enter into Point-of-Care Infectious Disease Diagnostics/Testing Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2014-2019)
    • 4.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2014-2019)
    • 5.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in United States
    • 5.3 United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type
    • 5.4 United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application

    6 Europe

    • 6.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2014-2019)
    • 6.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Europe
    • 6.3 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type
    • 6.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application

    7 China

    • 7.1 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2014-2019)
    • 7.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in China
    • 7.3 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type
    • 7.4 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application

    8 Japan

    • 8.1 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2014-2019)
    • 8.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Japan
    • 8.3 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type
    • 8.4 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2014-2019)
    • 9.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Southeast Asia
    • 9.3 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type
    • 9.4 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application

    10 India

    • 10.1 India Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2014-2019)
    • 10.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in India
    • 10.3 India Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type
    • 10.4 India Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2014-2019)
    • 11.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Central & South America
    • 11.3 Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type
    • 11.4 Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application

    12 International Players Profiles

    • 12.1 Alere
      • 12.1.1 Alere Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Point-of-Care Infectious Disease Diagnostics/Testing Introduction
      • 12.1.4 Alere Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2014-2019)
      • 12.1.5 Alere Recent Development
    • 12.2 Thermo Fisher Scientific Inc
      • 12.2.1 Thermo Fisher Scientific Inc Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Point-of-Care Infectious Disease Diagnostics/Testing Introduction
      • 12.2.4 Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2014-2019)
      • 12.2.5 Thermo Fisher Scientific Inc Recent Development
    • 12.3 F. Hoffmann-La Roche Ltd
      • 12.3.1 F. Hoffmann-La Roche Ltd Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Point-of-Care Infectious Disease Diagnostics/Testing Introduction
      • 12.3.4 F. Hoffmann-La Roche Ltd Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2014-2019)
      • 12.3.5 F. Hoffmann-La Roche Ltd Recent Development
    • 12.4 Siemens Healthineers
      • 12.4.1 Siemens Healthineers Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Point-of-Care Infectious Disease Diagnostics/Testing Introduction
      • 12.4.4 Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2014-2019)
      • 12.4.5 Siemens Healthineers Recent Development
    • 12.5 BD & Company
      • 12.5.1 BD & Company Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Point-of-Care Infectious Disease Diagnostics/Testing Introduction
      • 12.5.4 BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2014-2019)
      • 12.5.5 BD & Company Recent Development
    • 12.6 Chembio Diagnostics Inc.
      • 12.6.1 Chembio Diagnostics Inc. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Point-of-Care Infectious Disease Diagnostics/Testing Introduction
      • 12.6.4 Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2014-2019)
      • 12.6.5 Chembio Diagnostics Inc. Recent Development
    • 12.7 Trinity Biotech
      • 12.7.1 Trinity Biotech Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Point-of-Care Infectious Disease Diagnostics/Testing Introduction
      • 12.7.4 Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2014-2019)
      • 12.7.5 Trinity Biotech Recent Development
    • 12.8 Cardinal Health
      • 12.8.1 Cardinal Health Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Point-of-Care Infectious Disease Diagnostics/Testing Introduction
      • 12.8.4 Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2014-2019)
      • 12.8.5 Cardinal Health Recent Development
    • 12.9 Quest Diagnostics Inc.
      • 12.9.1 Quest Diagnostics Inc. Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Point-of-Care Infectious Disease Diagnostics/Testing Introduction
      • 12.9.4 Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2014-2019)
      • 12.9.5 Quest Diagnostics Inc. Recent Development
    • 12.10 Bio-Rad Labs Inc.
      • 12.10.1 Bio-Rad Labs Inc. Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Point-of-Care Infectious Disease Diagnostics/Testing Introduction
      • 12.10.4 Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2014-2019)
      • 12.10.5 Bio-Rad Labs Inc. Recent Development
    • 12.11 bioMérieux SA
    • 12.12 Sight Diagnostics Ltd.
    • 12.13 Gene POC
    • 12.14 Trivitron Healthcare
    • 12.15 OJ-Bio Ltd.
    • 12.16 Ortho-Clinical Diagnostics

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Point-of-Care Infectious Disease Diagnostics/Testing market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Point-of-Care Infectious Disease Diagnostics/Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Point-of-Care Infectious Disease Diagnostics/Testing development in United States, Europe and China.

      The key players covered in this study
      Alere
      Thermo Fisher Scientific Inc
      F. Hoffmann-La Roche Ltd
      Siemens Healthineers
      BD & Company
      Chembio Diagnostics Inc.
      Trinity Biotech
      Cardinal Health
      Quest Diagnostics Inc.
      Bio-Rad Labs Inc.
      bioMérieux SA
      Sight Diagnostics Ltd.
      Gene POC
      Trivitron Healthcare
      OJ-Bio Ltd.
      Ortho-Clinical Diagnostics

      Market segment by Type, the product can be split into
      HIV POC
      Clostridium difficile POC
      HBV POC
      Pneumonia or Streptococcus associated infections
      Respiratory syncytial virus (RSV) POC
      HPV POC
      Influenza/Flu POC
      Other Infectious Disease POC

      Market segment by Application, split into
      Hospitals
      Clinics
      Home
      Assisted Living Healthcare Facilities
      Laboratories
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Point-of-Care Infectious Disease Diagnostics/Testing status, future forecast, growth opportunity, key market and key players.
      To present the Point-of-Care Infectious Disease Diagnostics/Testing development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Point-of-Care Infectious Disease Diagnostics/Testing are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now